Private-credit & direct-lending funds

Growth Lending

Growth Lending, formerly BOOST&Co, lends £2m to £10m of covenant-lite growth and acquisition term loans to established, revenue-generating UK SMEs, from software to private healthcare and defence.

Considering finance for your business? Discuss the lender options.

Fig. 01

Published band £2m to £10m, against the other 59 private-credit and direct-lending funds.

Growth Lending publishes £2m to £10m.Growth Lending's published facility band, £2m to £10m, drawn on a logarithmic axis from £100k to £100m against the £3m to £15m band and the shaded field of the other 59 private-credit and direct-lending funds, which is taller where more of them publish a band covering that size.£3–15m£2m£10m£100k£1m£10m£100m
Published facility bands: Growth Lending against the other private-credit and direct-lending funds in this directory.
LenderPublished band
Growth Lending£2m to £10m
The other private-credit and direct-lending funds28 of 59 publish a band; at the field's peak 23 of them cover the same facility size
The band this directory reads for£3m to £15m

The shaded field is the other 59 private-credit and direct-lending funds in this directory, taller where more of them publish a band covering that size. Growth Lending’s bar is its own published range. A band is what a lender states it will do, not what it will do on a given credit.

What they do

Growth Lending is the name BOOST&Co now trades under: a UK specialist lender that provides term debt to established, high-growth SMEs as a non-dilutive alternative to raising more equity. BOOST&Co Limited was incorporated in August 2011, and the lender dates its support for high-growth businesses to 2013. It lends from committed fund capital, and British Business Investments backed both of its first two funds. In 2020 it bought GapCap and KX Media Capital, bringing three brands together as the Growth Lending Group. Its current product menu lists growth loans, acquisition finance, healthcare finance for the private healthcare sector, SME loans, management buyout funding, and defence, security and resilience loans for companies executing complex, high-value contracts. Growth loans run from £2m to £10m, and acquisition finance up to £10m. Growth Lending says it has supported more than 200 UK businesses and deployed more than £1bn, and it raises money from institutional investors seeking exposure to secured, asset-backed SME debt. Its website also links to a separate US site.

Who they lend to

The borrower is an established company that has moved past early-stage risk, with proven product-market fit and, in Growth Lending's words, strong recurring revenue and a clear path forward. Its growth credit criteria require a UK-registered B2B business with revenue above £2m and more than 12 months of trading, and it says it typically targets revenues between £5m and £50m. Sectors named include software, telecommunications, financial services, business services, life sciences and national security, now joined by dedicated lines for private healthcare and for defence, security and resilience. It can lend before profitability where there is a clear runway to it, so there is no EBITDA floor, and it looks beyond balance-sheet collateral, so a business with high revenues and few hard assets is in scope. Founder-led, owner-managed and venture-backed companies all qualify, and management teams buying a business can apply for buyout funding. Lending is UK-wide, with some activity in Europe.

How they structure a facility

The standard instrument is a senior secured term loan under a debenture, at a floating rate, over a term of typically three to five years; loans are often repaid within two to three. Growth loans and acquisition finance draw down in tranches against commercial milestones, and Growth Lending charges no non-utilisation fee on undrawn acquisition amounts. Repayment is shaped around growth: typically up to 12 months of interest-only, after which capital and interest amortise over the remaining term. Growth Lending describes the facilities as covenant-lite. It calls the debt non-dilutive, although its growth loans page speaks of minimal equity dilution, and it publishes no warrant terms. Personal guarantees are rarely required, because the firm says it lends against enterprise value, recurring revenue and cash flow rather than hard assets. Its healthcare line is pitched on a higher loan-to-value than elsewhere in the market. Growth Lending does not publish its pricing or a leverage limit.

Published terms

Pricing
Not published; acquisition finance carries no non-utilisation fees on undrawn amounts
Published by 1 of 60
Speed to terms
No timetable published; Growth Lending cites swift decisions
Published by 8 of 60
Sponsored or sponsorless
Both: founder-led, owner-managed and venture-backed companies, and management teams through its listed management buyout funding
Where they lend
UK-wide (also some Europe)
How they decide
Asset-manager an investment committee model; regional offices (London/Manchester/Leeds/Birmingham/Bristol/Cambridge); an investment committee cadence not published
Covenants
Covenant-lite, in Growth Lending's description of its growth loans and acquisition finance
Published by 15 of 60
Personal guarantee
Not typically required on the published terms: Growth Lending states personal guarantees are rarely required on its term loans
Published by 2 of 60

As published by the lender and last reviewed October 2026. Terms quoted on a deal are set by the credit, not by a published band.

How a deal reaches them

Companies can apply direct through the enquiry form on each product page. It asks for revenue, business type and sector, the amount sought in bands from £1m to over £10m, and the purpose, from growth and working capital to refinancing, M&A and buyouts. Introducers form the second channel: Growth Lending says it works closely with its professional network to reach growing businesses. Debt finance directors cover London and the South East from London and the North from Manchester, and the firm has also described offices in Leeds, Birmingham, Bristol and Cambridge. Credit decisions sit with an investment committee whose cadence is unpublished. Growth Lending promises swift decisions but gives no timetable. The case it reads is the growth story: recurring revenue, the use of funds and a credible route to repayment.

Where they fit in a lower-mid-market raise

The natural call is an established, revenue-generating business, often in software, healthcare or business services, that wants £2m to £10m to fund an acquisition, a buy-and-build programme, R&D or expansion without issuing more equity. Its acquisition finance has backed buy-and-build platforms in consulting and domiciliary care, and the tranche structure suits a pipeline of bolt-ons drawn as each completes. Its £10m loan size reaches the lower and middle of a £3m to £15m raise, not the top. Its nearest names are the growth and venture lenders Kreos, Claret, Salica and Palatine Growth Credit, which also underwrite recurring revenue and runway where there is no EBITDA to multiply. Growth Lending's own entry test is proven product-market fit and established revenue rather than a recent venture round, and its buyout line brings management teams buying their company into scope.

Where they are not the fit

Pre-revenue start-ups, distressed businesses and property or asset plays are out, as is any company under the £2m revenue floor or with less than 12 months of trading. Growth Lending says growth credit is the wrong tool for an unproven model, highly volatile revenue, a business that cannot comfortably support repayments, or one borrowing mainly to cover persistent losses or with no defined use for the money. Consumer-facing businesses sit outside the B2B requirement of its growth credit. A facility above £10m is beyond its stated loan size, so the top of a £3m to £15m raise needs a second lender. Growth Lending looks past hard assets to revenue and growth, so a borrower whose case rests on collateral is not its target.

What rules a deal out

Stated limits, taken from Growth Lending’s own published criteria. A limit is where a lender starts from, not where it always ends: several of these move on a strong enough credit.

  • Revenue >£3m typical
  • Beyond startup phase required
  • Revenue/ARR-led not EBITDA-multiple
  • Revenue >£2m (growth credit) or >£3m (term loans); UK-registered; 12+ months trading; B2B model required
  • No appetite in distressed, pre-revenue startups or property

How they sit against the category

  • Its published ceiling is £10m; 25 of the 60 private-credit funds here go at least as high.
  • It opens lower than almost all of them, at £2m.
  • Like 59 of the 60, it publishes no indicative price; a margin comes from a conversation, not a page.

Counted across the 60 private-credit & direct-lending funds in this directory, on what each one publishes. What a lender discloses and what it will do are different things.

Recent activity on the public record

In June 2017, BOOST&Co's first fund, writing venture debt of £2m to £8m, had committed about £100m to UK SMEs. In May 2019, British Business Investments committed £50m to its second fund, Industrial Lending II, after putting £40m into the fully invested first fund across 37 high-growth SMEs. In 2020, it acquired GapCap and KX Media Capital, and the combined group now trades as Growth Lending. As of October 2026, Growth Lending reported more than 200 UK businesses supported and more than £1bn deployed.

On the record

  • BOOST&Co Limited incorporated 3 August 2011; Companies House number 07728296; status Active; SIC 64303 (Activities of venture and development capital companies); registered office 19th Floor, 1 Westfield Avenue, London E20 1HZ.

    Companies House

  • Authorised and regulated by the Financial Conduct Authority; FCA reference number 711918.

    British Business Investments press release, May 2019

  • British Business Investments committed £50m to BOOST&Co's second fund, Industrial Lending II s.a., in May 2019, following a fully-invested first fund (Industrial Lending I) in which BBI had committed £40m across 37 high-growth SMEs.

    British Business Bank press release, 2 May 2019

  • BOOST&Co's Industrial Lending I fund provided venture debt of £2m–£8m to innovative, fast-growing companies; the fund made total commitments of approximately £100m across 33–37 UK SMEs.

    British Business Bank press release, 29 June 2017

  • Under the Growth Lending brand, the firm provides growth credit of £2m to £10m to UK-registered B2B businesses with revenues above £2m and a trading history of more than 12 months, drawn in tranches over a term typically of three to five years and secured by a debenture.

    Growth Lending, Growth Credit

  • Growth Lending targets high-quality growth companies in software, telecommunications, financial services, business services, life sciences and national security, typically with revenues between £5m and £50m.

    Growth Lending, Funding for Growth

  • In 2020, BOOST&Co acquired GapCap and KX Media Capital, consolidating three brands under the Growth Lending Group; the entity now operates publicly as Growth Lending.

    Insider Media / Manchester Digital

Questions this page answers

What is the minimum and maximum loan from Growth Lending?

Growth Lending offers growth loans from £2m to £10m, and its acquisition finance runs up to £10m, drawn in tranches with no non-utilisation fees on undrawn amounts.

As published at growthlending.com

Does Growth Lending take a personal guarantee?

Growth Lending states that personal guarantees are rarely required, because it lends against enterprise value, recurring revenue and cash flow. Its growth loans page adds that no hard assets are required.

As published at growthlending.com

Does Growth Lending fund management buyouts?

Yes. Management Buyout Funding is one of the products Growth Lending lists, alongside growth loans, acquisition finance, healthcare finance, SME loans and national security lending, and its enquiry form names MBOs and MBIs as a purpose.

As published at growthlending.com

How long is the interest-only period on a Growth Lending loan?

Growth Lending says its growth loans and acquisition finance typically carry up to 12 months of interest-only, with capital and interest then amortising over the remaining term. Funds can be drawn in tranches against commercial milestones.

As published at growthlending.com

What covenants does Growth Lending set?

Growth Lending describes its growth loans and acquisition finance as covenant-lite facilities that do not dilute the borrower's equity. It does not publish the covenant tests themselves.

As published at growthlending.com

Who does Growth Lending lend to?

Growth Lending says it partners with established companies that have moved past early-stage risk and have proven product-market fit, strong recurring revenue and a clear path forward. It looks beyond balance-sheet collateral, so no hard assets are required.

As published at growthlending.com

Is Growth Lending still lending under the BOOST&Co name?

No. The business trades as Growth Lending, and its website names Growth Lending Ltd, with a principal place of business at 15 Crinan Street, London. BOOST&Co acquired GapCap and KX Media Capital in 2020 to form the Growth Lending Group.

As published at growthlending.com

Does BOOST&Co (now Growth Lending) lend to companies without a private-equity sponsor?

Yes. BOOST&Co (now Growth Lending) lends to owner-managed and sponsor-backed borrowers alike, so a company with no private-equity backer is not out of scope on that ground.

Sources: growthlending.com · uk.linkedin.com

Terms used on this page: Springing covenant · Personal guarantee · Sponsor · Acquisition finance · Non-utilisation fee

This profile is a curated reference note drawn from public sources, not financial advice or a recommendation. Appetite and terms change; a lender's fit for a given credit is established by approaching it, not inferred from a page.

SolonCorporate Finance

Independent debt advisory for UK lower-mid-market companies.

Discuss your financing

© 2026 Solon Corporate Finance Ltd. Registered in England & Wales, company number 17320026.

Registered office: 124 City Road, London EC1V 2NX.

Solon Corporate Finance Ltd advises on and arranges commercial debt facilities for UK companies. Arranging and advising on plain commercial lending to corporate borrowers is not a regulated activity under FSMA, and Solon is not authorised or regulated by the Financial Conduct Authority.